Identification of a bradykinin-generating hypotensive substance in plasma protein fraction: prekallikrein activator (PKA-beta-Xiia)
Bakker, J.C.; de Vries-van Rossen, A.; Radema, H.; Bleeker, W.; Ufkes, J.G.; van Rosevelt, R.F.; van Mourik, J.A.
Advances in Experimental Medicine and Biology 156: 1091-1097
1983
ISSN/ISBN: 0065-2598 PMID: 6602466 Document Number: 205904
Document emailed within 1 workday
Related Documents
English, D.; Schell, M.; Siakotos, A.; Gabig, T.G. 1986: Reversible activation of the neutrophil superoxide generating system by hexachlorocyclohexane: correlation with effects on a subcellular superoxide-generating fraction Journal of Immunology 137(1): 283-290Gallimore, M.J.; Friberger, P. 1984: Prekallikrein activator Thrombosis and Haemostasis 52(3): 366
Degtiar, V.G. 1983: Specific binding of 5 alpha-androstan-3 beta, 17 beta-diol to protein fraction pituitary cytosol of female rats Endocrinologia Experimentalis 17(2): 145-153
Delacourte, A.; Flament, S.; Behrouz, N.; Defossez, A. 1989: Alzheimer's disease: tau microtubular protein and beta protein A4 constitute 2 different types of amyloid substance Acta Neurologica Belgica 89(3-4): 274-275
Lämmle, B.; Lohri, A.; Tran, T.H.; Czendlik, C. 1984: Amidolytic prekallikrein (PK) assay: unsuitability of Cephotest as an activator Thrombosis and Haemostasis 51(2): 294
Imamura, T.; Dubin, A.; Moore, W.; Tanaka, R.; Travis, J. 1996: Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens Laboratory Investigation; A Journal of Technical Methods and Pathology 74(5): 861-870
Liu, W.P.; Humphries, A.L.; Russell, R.; Stoddard, L.D.; Garcia, L.A.; Serkes, K.D. 1973: Three- and seven-day perfusion of dog kidney with human plasma protein fraction IV-4 Surgical Forum 24: 316-318
Suzuki, N.; Matsunaga, T.; Kanaho, Y.; Nozawa, Y. 1993: The mechanism of bradykinin-induced arachidonic acid release in osteoblast-like MC3T3-E1 cells phospholipase A2 activation by bradykinin and its regulation by protein kinase C and calcium Nihon Seikeigeka Gakkai Zasshi 67(10): 935-943
Berglöf, J.H.; Eriksson, S.; Andersson, I. 1987: New supports for plasma protein fraction: optimization and application of gel filtration using an improved sephacryl S-200 gel Developments in Biological Standardization 67: 25-29
Boutsikas, G.; Terpos, E.; Markopoulos, A.; Papatheodorou, A.; Stefanou, A.; Georgiou, G.; Galani, Z.; Komninaka, V.; Telonis, V.; Anagnostopoulos, I.; Dimitrakopoulou, L.; Anargyrou, K.; Tsionos, K.; Christoulas, D.; Gonianaki, M.; Giannikos, T.; Kokoris, S.; Konstantopoulos, K.; Meletis, J.; Angelopoulou, M.K.; Travlou, A.; Vassilakopoulos, T.P. 2017: Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL) Journal of BUON: Official Journal of the Balkan Union of Oncology 22(4): 1022-1031
Altinkurt, O.; Kanzik, I. 1980: Inhibitory effects of streptomycin on bronchoconstrictor, hypotensive and inflammatory responses to bradykinin and histamine Archives Internationales de Pharmacodynamie et de Therapie 246(2): 277-285
Sattar, N.; McMillan, D.C. 1998: Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer. Measuring C reactive protein concentrations may be more useful Bmj 317(7160): 750-751
Zebrowska-Lupina, I.; Kolber-Postepska, B.; Markiewicz, M.; Horubała-Bielak, G. 1994: Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension Wiadomosci Lekarskie 47(7-8): 241-247
Lillo-Ferez, M.; Dupommereulle, C.; Prieur, P.; Petrover, M. 1986: Levels of plasma beta 2-microglobulin and deposits of amyloid substance in patients under chronic hemodialysis Nephrologie 7(5): 211
Johnson, R.W.; Cohen, G.L.; Mallick, N.P.; Orr, W.M. 1979: Renal function and early cadaver graft survival after continuous hypothermic perfusion with plasma protein fraction (PPF) Transplantation Proceedings 11(2): 1476
Waeber, B.; Nussberger, J.; Brunner, H.R.; de Agostini, A.; Schapira, M. 1984: Hypotensive effect of human factor XIi active fragment in conscious normotensive rats: role of bradykinin Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 2(3): S341-S342
Perrier, H.; Perrier, C.; Pérès, G.; Gras, J. 1979: Immediate effects of thermal shocks on the plasma level of various components in the Rainbow trout: compounds indicating stress and protein fraction Revue Canadienne de Biologie 38(1): 37-41
Egberg, N.; Gallimore, M.J. 1983: Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material Advances in Experimental Medicine and Biology 156: 1109-1117
Tardif, G.; Reboul, P.; Dupuis, M.; Geng, C.; Duval, N.; Pelletier, J.P.; Martel-Pelletier, J. 2001: Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites Journal of Rheumatology 28(7): 1631-1639
Henry, J.L. 1979: Roles of peptides in central transmission: substance P, bradykinin and B-endorphin International Journal of Neurology 13(1-4): 167-179